Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kurt Gebauer

6PUBLICATIONS

22CO-AUTHORS

Haematological tumoursTransport properties and non-equilibrium processesClinical pharmacology and therapeuticsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jan 09, 2026

Retrospective Analysis of the Recurrence of Atypical Fibroxanthoma When Treated With Curettage and Cautery at a Single Centre.

Nehel Binte-Mehdi Syed, Kurt Gebauer

|Dec 29, 2025

Delayed Bullous Drug Eruption Induced by Elexacaftor/Tezacaftor/Ivacaftor.

Tatiana Ninkov, Megan Yap, Nima Mesbah Ardakani

|Aug 05, 2025

Guidelines for Phototherapy and PUVA Service Delivery in Australia: Minimum Standards and Quality Assurance Framework.

Stephanie Tan, Kurt GeBauer

|May 14, 2025

Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology Group.

Marius Rademaker, Peter Foley, Katherine Armour

|Dec 31, 2024

Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series.

Conor Larney, Peter Foley, Kurt Gebauer

|Jul 28, 2023

Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Adult patients.

Peter Foley, Kurt Gebauer, John Sullivan

Pageof 1

Frequent Collaborators

3 joint publications

Peter Foley

2 joint publications

John Sullivan

2 joint publications

Erin McMeniman

2 joint publications

Christopher Baker

1 joint publications

Stephen Shumack

1 joint publications

Jonathan Ng

1 joint publications

Amelia James

1 joint publications

Morton Rawlin

1 joint publications

Shireen Sidhu

1 joint publications

Dev Tilakaratne

Frequent Collaborators

3 joint publications

Peter Foley

2 joint publications

John Sullivan

2 joint publications

Erin McMeniman

2 joint publications

Christopher Baker

Top Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on : Nov 07, 2025

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Minimal Erythema Dose (MED) Testing

Minimal Erythema Dose (MED) Testing

Published on : May 28, 2013

See more related videos

Top Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on : Nov 07, 2025

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Minimal Erythema Dose (MED) Testing

Minimal Erythema Dose (MED) Testing

Published on : May 28, 2013

See more related videos